Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1341, doi. 10.1177/10600280231164500
- By:
- Publication type:
- Article
Works matching IS 10600280 AND DT 2023 AND VI 57 AND IP 11
Results: 11
1
2
Critical Care Pharmacist Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1282, doi. 10.1177/10600280231160437
- By:
- Publication type:
- Article
3
Medical Outcomes of Acute Aspirin Single Substance Poisoning in Pediatric Patients.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1273, doi. 10.1177/10600280231159898
- By:
- Publication type:
- Article
4
Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Narrative Review.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1312, doi. 10.1177/10600280231158809
- By:
- Publication type:
- Article
5
A Review of the Data Supporting Use of COVID-19 Vaccinations in the Pediatric Population.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1328, doi. 10.1177/10600280231156625
- By:
- Publication type:
- Article
6
The Medication Possession Ratio as a Predictor of Longitudinal HIV-1 Viral Suppression.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1264, doi. 10.1177/10600280231156624
- By:
- Publication type:
- Article
7
Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1255, doi. 10.1177/10600280231156270
- By:
- Publication type:
- Article
8
Acute Management of Hypertriglyceridemia With a Disease-Specific Intravenous Insulin Infusion Order Set.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1248, doi. 10.1177/10600280231155921
- By:
- Publication type:
- Article
9
Updates in the Treatment of Non-Metastatic Castrate-Resistant Prostate Cancer: The Benefit of Second-Generation Androgen Receptor Antagonists.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1302, doi. 10.1177/10600280231155441
- By:
- Publication type:
- Article
10
Intravenous or Oral Acetazolamide for Treatment of Diuretic-Induced Alkalosis in Patients With Heart Failure.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1241, doi. 10.1177/10600280231154603
- By:
- Publication type:
- Article
11
Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 11, p. 1291, doi. 10.1177/10600280231154021
- By:
- Publication type:
- Article